| Literature DB >> 16616975 |
Laura A Novotny1, Joseph A Jurcisek, Fabrice Godfroid, Jan T Poolman, Philippe A Denoël, Lauren O Bakaletz.
Abstract
Passive transfer of a pediatric human serum pool generated against polysaccharide-protein D conjugate vaccines conferred approximately 34% protection against development of ascending NTHI-induced OM when used in a chinchilla viral-bacterial co-infection model. These data are in line with results obtained using a similar 11-valent-protein D conjugate vaccine in a pediatric clinical trial, wherein a vaccine efficacy of 35.6% was shown against acute OM episodes caused by NTHI. These observations strongly support the chinchilla passive transfer-superinfection model as one that could predict clinical trials outcomes for vaccines to prevent NTHI-induced OM.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16616975 DOI: 10.1016/j.vaccine.2006.03.021
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641